Physician profile
Darren Haskell
NPI 1689636813
$4,559.91
in general payments reported to CMS, 2019-2025
37 companies · $671 in 2025
The $671 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,353 · 2020: $258 · 2021: $138 · 2022: $654 · 2023: $914 · 2024: $572 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,091 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,090.53 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $480.09 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $378.62 | 2019-2025 | |
| Amgen INC. | $376.29 | 2019-2025 | Evenity, Otezla, Repatha |
| Abbvie INC. | $352.38 | 2019-2025 | |
| Novo Nordisk INC | $301.78 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $267.92 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $229.14 | 2019-2025 | Jardiance, Mounjaro, Taltz |
| Janssen Pharmaceuticals, INC | $222.07 | 2019-2022 | |
| Astellas Pharma US INC | $208.18 | 2019-2023 | Myrbetriq, Veozah |
| Amarin Pharma, INC. | $203.44 | 2019-2022 | |
| Janssen Biotech, INC. | $161.20 | 2019-2024 | Tremfya |
| Abbott Laboratories | $159.35 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Ucb, INC. | $145.70 | 2019-2025 | Cimzia, Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $127.74 | 2019-2024 | Eliquis |
| Stryker Corporation | $94.23 | 2025 | Blueprint Patient Specific Instrumentation |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Haskell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.